Edible Vaccine Market 2024: Key Growth Drivers & Opportunities

The edible vaccine global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Edible Vaccine Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size
The edible vaccine market size has grown strongly in recent years. It will grow from $8.04 billion in 2023 to $8.77 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to advancements in genetic engineering, challenges with traditional vaccines, advances in biopharming, growing focus on global immunization, and increasing funding and support from governments.

The edible vaccine market size is expected to see strong growth in the next few years. It will grow to $12.50 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to the growing demand for pandemic preparedness, advancements in plant biotechnology, growing public awareness and acceptance of genetically modified foods, addressing cold chain challenges, and integration with food security initiatives. Major trends in the forecast period include expansion into animal health, increased use of biopharming, personalized nutrition and vaccination, sustainability and green vaccines, and the development of multi-antigen edible vaccines.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/edible-vaccine-global-market-report

Scope Of Edible Vaccine Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Edible Vaccine Market Overview

Market Drivers
The increasing prevalence of infectious diseases is expected to propel the growth of the edible vaccine market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that invade the body and multiply. The increasing prevalence of infectious diseases is mainly due to factors such as globalization, climate change, urbanization, and antibiotic resistance, which facilitate the spread and emergence of new pathogens. Edible vaccines are used in infectious diseases to stimulate immune responses by consuming genetically modified foods that produce antigens, offering a cost-effective and needle-free method of immunization. For instance, in March 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, the number of tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. Additionally, the rate per 100,000 people went up from 2.5 in 2022 to 2.9 in 2023. Therefore, the increasing prevalence of infectious diseases is driving the growth of the edible vaccine market.

Market Trends
Major companies operating in the edible vaccine market are focusing on developing innovative solutions, such as oral cholera vaccine (OCV), to combat the global cholera crisis. Oral cholera vaccine (OCV) is a type of vaccine administered by mouth to prevent cholera, a severe diarrheal disease caused by the bacterium Vibrio cholerae. For instance, in August 2024, Bharat Biotech International Limited, an India-based biotechnology company, launched the Hillchol, an oral cholera vaccine (OCV) with several notable features. This live-attenuated vaccine stimulates both systemic and mucosal immune responses, protecting against cholera. Hillchol stands out for its ease of administration and does not require cold storage, making it ideal for use in resource-limited settings. Moreover, it offers long-lasting immunity with just a single dose.

The edible vaccine market covered in this report is segmented –

1. By Type: Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Live Attenuated Vaccines, Other Types
2. By Distribution Channel: Hospitals, Veterinary Clinics, Retail Pharmacies, Online Pharmacies
3. By Application: Medical Care, Livestock, Aquaculture, Agriculture, Other Applications
4. By End User: Adults, Pediatrics, Animals

Get an inside scoop of the edible vaccine market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19040&type=smp

Regional Insights
North America was the largest region in the edible vaccine market in 2023. The regions covered in the edible vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Key Companies
Major companies operating in the edible vaccine market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., GSK plc, C.H. Boehringer Sohn AG & Co. KG, Novavax Inc., Ceva Santé Animale, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Zydus Lifesciences Limited, Bharat Biotech International Limited, Medicago Inc., CureVac N.V., Profectus BioSciences Inc., Vaxart Inc., China National Biotec Group Company Limited, Vaxine Pty Ltd., Vaxiion Therapeutics Inc., Therapix Biosciences Ltd., Mymetics Corporation.

Table of Contents 

1. Executive Summary

2. Edible Vaccine Market Report Structure

3. Edible Vaccine Market Trends And Strategies

4. Edible Vaccine Market – Macro Economic Scenario

5. Edible Vaccine Market Size And Growth

…..

27. Edible Vaccine Market Competitor Landscape And Company Profiles

28. Key Mergers And Acquisitions

29. Future Outlook and Potential Analysis

30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model